Differences in the concentration and correlation of cervical immune markers among HPV positive and negative perimenopausal women

Cytokine

Volumn 56, Issue 3, 2011, Pages 798-803

  Marks, Morgan A ^a   Viscidi, Raphael P ^b   Chang, Kathryn ^a   Silver, Michelle ^a   Burke, Anne ^b   Howard, Roslyn ^a   Gravitt, Patti E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

EOTAXIN; Human papillomavirus; Interleukin 2; Menopause

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; EOTAXIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLIMACTERIUM; CONCENTRATION (PARAMETERS); CONDYLOMA ACUMINATUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; PRIORITY JOURNAL; PROSPECTIVE STUDY; T LYMPHOCYTE; VERRUCA VULGARIS; WART VIRUS;

BIOLOGICAL MARKERS; CERVIX UTERI; CYTOKINES; FEMALE; GENE REGULATORY NETWORKS; HUMANS; HYPERSENSITIVITY; INFLAMMATION; LIMIT OF DETECTION; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PERIMENOPAUSE; T-LYMPHOCYTES;

HUMAN PAPILLOMAVIRUS;

EID: 81455158723     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.09.012     Document Type: Article

References (30)

1. Munoz N., Castellsague X., de Gonzalez A.B., Gissmann L. HPV in the etiology of human cancer. Vaccine 2006, 24S3:S1-S10. (Chapter 1).
2. de Sanjose S., Diaz M., Castellsague X., Clifford G., Bruni L., Munoz N., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7:453-459.
3. Stanley M. Immune responses to human papillomavirus. Vaccine 2006, 24 Suppl. 1:S16-S22.
4. Garcia-Pineres A.J., Hildesheim A., Herrero R., Trivett M., Williams M., Atmetlla I., et al. Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women. Cancer Res 2006, 66:11070-11076.
5. Kemp T.J., Hildesheim A., Garcia-Pineres A., Williams M.C., Shearer G.M., Rodriguez A.C., et al. Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 2010, 19:1954-1959.
6. Castle P.E., Hildesheim A., Bowman F.P., Strickler H.D., Walker J.L., Pustilnik T., et al. Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levels. J Clin Immunol 2002, 22:23-27.
7. Kemp T.J., Garcia-Pineres A., Falk R.T., Poncelet S., Dessy F., Giannini S.L., et al. Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women. Vaccine 2008, 26:3608-3616.
8. Gravitt P.E., Hildesheim A., Herrero R., Schiffman M., Sherman M.E., Bratti M.C., et al. Correlates of IL-10 and IL-12 concentrations in cervical secretions. J Clin Immunol 2003, 23:175-183.
9. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutlee F., Hildesheim A., et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000, 38:357-361.
10. Coutlee F., Gravitt P., Kornegay J., Hankins C., Richardson H., Lapointe N., et al. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 2002, 40:902-907.
11. Nardelli-Haefliger D., Wirthner D., Schiller J.T., Lowy D.R., Hildesheim A., Ponci F., et al. Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Inst 2003, 95:1128-1137.
12. Bio-Rad Laboratories I. Bio-Plex suspension array system tech note. Hercules, CA; 2005.
13. Bio-Rad Laboratories I. Bio-Plex pro human cytokine, chemokine, and growth factor assays technical bulletin. 2009. p. 1-4.
14. Jespers V., Francis S.C., van de Wijgert J., Crucitti T. Methodological issues in sampling the local immune system of the female genital tract in the context of HIV prevention trials. Am J Reprod Immunol 2011, 65:368-376.
15. Jespers V., Harandi A.M., Hinkula J., Medaglini D., Le Grand R., Stahl-Hennig C., et al. Assessment of mucosal immunity to HIV-1. Expert Rev Vaccine 2010, 9:381-394.
16. UCLA: Academic technology services SCG. Sidak-Holm: adjusted p-values. Available from: (accessed 17 July 2011). http://www.ats.ucla.edu/stat/stata/code/sidak_holm.htm.
17. Pope S.M., Brandt E.B., Mishra A., Hogan S.P., Zimmermann N., Matthaei K.I., et al. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J Allergy Clin Immun 2001, 108:594-601.
18. Rothenberg M.E., Zimmermann N., Mishra A., Brandt E., Birkenberger L.A., Hogan S.P., et al. Chemokines and chemokine receptors: their role in allergic airway disease. J Clin Immunol 1999, 19:250-265.
19. Zimmermann N., Hershey G.K., Foster P.S., Rothenberg M.E. Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immun 2003, 111:227-242. quiz 243.
20. Martinelli-Klay CP, Mendis BR, Lombardi T. Eosinophils and oral squamous cell carcinoma: a short review. J Oncol 2009:310132.
21. de Jong A., van Poelgeest M.I., van der Hulst J.M., Drijfhout J.W., Fleuren G.J., Melief C.J., et al. Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res 2004, 64:5449-5455.
22. Hamilton J.A. GM-CSF in inflammation and autoimmunity. Trends Immunol 2002, 23:403-408.
23. Schrum S., Probst P., Fleischer B., Zipfel P.F. Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response. J Immunol 1996, 157:3598-3604.
24. Hubert P., Doyen J., Capelle X., Arafa M., Renoux V., Bisig B., et al. Local applications of GM-CSF induce the recruitment of immune cells in cervical low-grade squamous intraepithelial lesions. Am J Reprod Immunol 2010, 64:126-136. New York, NY.
25. Soroosh P., Doherty T.A. Th9 and allergic disease. Immunology 2009, 127:450-458.
26. Neill D.R., McKenzie A.N. Nuocytes and beyond: new insights into helminth expulsion. Trends Parasitol 2011, 27:214-221.
27. Stanley M. Immunobiology of HPV and HPV vaccines. Gynecol Oncol 2008, 109:S15-S21.
28. Cosmi L., Liotta F., Maggi E., Romagnani S., Annunziato F. Th17 cells: new players in asthma pathogenesis. Allergy 2011, 66:989-998.
29. Zhang Y., Ma D., Tian Y., Wang X., Qiao Y., Cui B. The imbalance of Th17/Treg in patients with uterine cervical cancer. Clin Chim Acta 2011, 412:894-900.
30. Ryckman K.K., Simhan H.N., Krohn M.A., Williams S.M. Cervical cytokine network patterns during pregnancy: the role of bacterial vaginosis and geographic ancestry. J Reprod Immunol 2009, 79:174-182.